Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 64, Issue 7
Volume 64, Issue 7
1 April 2017
ISSN 1058-4838
EISSN 1537-6591

Volume 64, Issue 7, 1 April 2017

NEWS

Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages i–ii, https://doi.org/10.1093/cid/cix030

IN THE LITERATURE

Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages iii–iv, https://doi.org/10.1093/cid/cix050

INVITED COMMENTARY

Arturo Casadevall
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 823–828, https://doi.org/10.1093/cid/cix067

The development of nontoxic broad-spectrum antimicrobial drugs in the mid-20th century led to a culture of empiricism, underdevelopment of diagnostics, neglect of immunotherapy, and selection for drug resistance, which together created the conditions that underlie the current crisis.

In 1996 an article in this journal predicted a crisis in infectious diseases, which subsequently unfolded with a paucity of new drugs, increases in antimicrobial resistance, and underdevelopment in both immunotherapy and diagnostics. This article argues that the root cause of the current-day problems lies in the enormous success of the mid-20th century antibiotic revolution. The availability of low-toxicity broad-spectrum drugs fostered a culture of empiricism and widespread use, which in turn stunted the development of both the specialty and rapid diagnostics while promoting increases in resistance. Two decades later, there are promising signs that widespread recognition of these problems is leading to fundamental changes in the approach to the therapy of infectious diseases. Ultimately, a concerted effort to simultaneously develop pathogen-specific drugs, immunotherapy, and improved diagnostics could provide a qualitatively new platform for confronting the challenge of infectious diseases, which now also includes host dysbiosis.

ARTICLES AND COMMENTARIES

Elisa Cordero and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 829–838, https://doi.org/10.1093/cid/ciw855

The use of 2 doses of influenza vaccine is safe and immunologically relevant in solid organ transplant recipients, with a number needed to treat for seroprotection and seroconversion <10, supporting the use of 2 vaccination doses after transplantation.

Jennifer H. Han and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 839–844, https://doi.org/10.1093/cid/ciw856

Carbapenem-resistant Klebsiella pneumoniae is a major public health threat, including in the long-term acute care hospital (LTACH) setting. We found a carbapenem resistance rate of 25% among K. pneumoniae clinical isolates from a network of 64 LTACHs in the United States. Resistance rates to gram-negative agents were also high, including a strikingly high prevalence of colistin/polymyxin B resistance of 16%.

Anne Kvistholm Jensen and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 845–851, https://doi.org/10.1093/cid/ciw860

We investigated the association between proton pump inhibitors (PPIs) and risk of listeriosis in Denmark, 1994-2012, using register data. The matched comorbidity adjusted odds ratio was 2.8 (95%CI: 2.1–3.7). PPIs may increase the risk of listeriosis in vulnerable populations groups.

Zheng Quan Toh and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 852–859, https://doi.org/10.1093/cid/ciw865

Our study demonstrated immune memory and antibody persistence for 6 years following 1 dose of quadrivalent HPV vaccine (4vHPV). Two doses of 4vHPV induced similar vaccine-type specific antibody response as 3 doses in girls who were vaccinated 6 years ago.

Meghan D. Morris and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 860–869, https://doi.org/10.1093/cid/ciw869

Using longitudinal data from geographically diverse community cohorts, this study informs disease etiology by describing hepatitis C virus (HCV) incidence temporal trends and related exposure behaviors, highlighting the impact early and sustained harm reduction strategies can have on HCV trends.

Michael Klompas and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 870–876, https://doi.org/10.1093/cid/ciw870
Sameer S. Kadri and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 877–885, https://doi.org/10.1093/cid/ciw871

Adjunctive intravenous immunoglobulin (IVIG) was infrequently used in patients with necrotizing fasciitis and shock at US academic hospitals. IVIG had no significant impact on mortality, even when administered within 2 days of hospitalization or specifically to patients with streptococcal or staphylococcal infections.

Kathy E. Raven and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 886–893, https://doi.org/10.1093/cid/ciw872

We generated genome sequence data from 293 Enterococcus faecium isolates from patients with bacteremia spanning 7 years in one hospital. Cases were connected to numerous transmission routes, the complexity of which placed them beyond detection by conventional infection control methods.

Shangxin Yang and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 894–901, https://doi.org/10.1093/cid/ciw876
Arthur W. Baker and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 902–911, https://doi.org/10.1093/cid/ciw877

We investigated and mitigated a 2-phase clonal outbreak of Mycobacterium abscessus linked to hospital tap water. A combination of tap water avoidance among high-risk patients, including lung transplant and cardiac surgery patients, and water engineering interventions terminated the outbreak.

Matthew B. Crist and Joseph F. Perz
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 912–913, https://doi.org/10.1093/cid/ciw881
Fok-Moon Lum and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 914–920, https://doi.org/10.1093/cid/ciw878

Zika virus startled the world with reports of increased microcephaly cases. Here, we demonstrate that Zika virus infects microglia in human fetal brain cells. This highlights a role for microglia and the development of neuroinflammation during congenital Zika virus pathogenesis.

Michelle Barton and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 921–927, https://doi.org/10.1093/cid/cix001

This manuscript describes a prospective study of early-onset neonatal candidiasis (congenital candidiasis) in extremely low birth weight infants and compares them to infants with late-onset disease and to controls. Early-onset disease predicts dissemination, cardiovascular end-organ damage, and high mortality.

John E. Bennett
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 928–929, https://doi.org/10.1093/cid/cix007
Klemen Strle and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 930–938, https://doi.org/10.1093/cid/cix002

Patients with Lyme disease often have pronounced TH17 inflammatory responses. Early in the infection, during erythema migrans, TH17 responses correlate with Borrelia burgdorferi antibodies, whereas late in the disease, in patients with antibiotic-refractory Lyme arthritis, these responses correlate with autoantibodies.

Peter Olupot-Olupot and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 939–946, https://doi.org/10.1093/cid/cix003

We have noted a recent upsurge in blackwater fever among children presenting to hospitals in eastern Uganda and speculate that this may relate to a change in policy toward new artemisinin-based combination therapies for malaria.

Tobias Broger and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 947–955, https://doi.org/10.1093/cid/cix023

Samples from >750 patients with presumptive TB in two continents were tested with a field-based IgG serological assay incorporating 57 M. tuberculosis antigens, and showed that responses to single antigens or multiple antigen sets have no clinically useful discriminating power.

Qianqian Qin and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 956–963, https://doi.org/10.1093/cid/cix031

We conducted a spatial analysis to identify epidemic foci and trends of HIV among men who have sex with men (MSM) in China. Assorted spatial analyses reveal concentrated HIV epidemic among young MSM in Chinese cities, calling for intensive interventions.

BRIEF REPORTS

Antonio Rivero-Juarez and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 964–966, https://doi.org/10.1093/cid/cix004
Somnuek Sungkanuparph and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 967–970, https://doi.org/10.1093/cid/cix036

PHOTO QUIZ

Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Page 971, https://doi.org/10.1093/cid/cix066

INVITED ARTICLE

ANTIMICROBIAL RESISTANCE

Pranita D. Tamma and Jesus Rodriguez-Baňo
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 972–980, https://doi.org/10.1093/cid/cix034

The continued rise in infections caused by extended-spectrum β-lactamase (ESBL)–producing pathogens is recognized globally as one of the most pressing concerns facing the healthcare community. We review the available data for the use of cephamycins, cefepime, piperacillin-tazobactam, ceftolozane-tazobactam, and ceftazidime-avibactam for the treatment of ESBL infections.

ANSWER TO THE PHOTO QUIZ

Sherif Beniameen Mossad
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 981–982, https://doi.org/10.1093/cid/cix070

CORRESPONDENCE

Didier Raoult
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Page 983, https://doi.org/10.1093/cid/cix037
James A. Seddon and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Page 984, https://doi.org/10.1093/cid/cix038
Niccolò Buetti and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 984–985, https://doi.org/10.1093/cid/cix040
Edward Stenehjem and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 985–986, https://doi.org/10.1093/cid/cix041
Oren Cohen and David Denning
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 986–987, https://doi.org/10.1093/cid/cix059
Peter J. Collignon and others
Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Pages 987–988, https://doi.org/10.1093/cid/cix061

COVER

Clinical Infectious Diseases, Volume 64, Issue 7, 1 April 2017, Page NP, https://doi.org/10.1093/cid/cix053
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close